Psyence Biomedical Receives Nasdaq Extension to Meet Continued Listing Rules

MT Newswires11/20 22:47

Psyence Biomedical Announces 1-For-75 Share Consolidation Will Begin Trading On A Post-Consolidated Basis At The Opening Of The Market On Tuesday, November 26, 2024

Benzinga11/20 05:24

Psyence Group Closes Disposal of PsyLabs Stake; Shares Fall

MT Newswires11/01 00:26

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga10/31 20:09

Press Release: Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group's Stake in PsyLabs

Dow Jones10/31 19:30

Psyence Biomedical Shares Are Trading Higher After the Company Announced the Recruitment of Its Australia-based Empax Center as the Second Trial Site for Psyence's Biomed Ongoing Phase IIb Clinical Trial of Nature-derived Psilocybin as a Potential...

Benzinga10/25 21:48